0001274737-21-000010.txt : 20210225
0001274737-21-000010.hdr.sgml : 20210225
20210225170545
ACCESSION NUMBER: 0001274737-21-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210223
FILED AS OF DATE: 20210225
DATE AS OF CHANGE: 20210225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adawi Kamal
CENTRAL INDEX KEY: 0001788393
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39049
FILM NUMBER: 21681488
MAIL ADDRESS:
STREET 1: C/O EXAGEN INC.
STREET 2: 1261 LIBERTY WAY, SUITE C
CITY: VISTA
STATE: CA
ZIP: 92131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXAGEN INC.
CENTRAL INDEX KEY: 0001274737
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1261 LIBERTY WAY
CITY: VISTA
STATE: CA
ZIP: 92081
BUSINESS PHONE: (760) 560-1501
MAIL ADDRESS:
STREET 1: 1261 LIBERTY WAY
CITY: VISTA
STATE: CA
ZIP: 92081
FORMER COMPANY:
FORMER CONFORMED NAME: EXAGEN DIAGNOSTICS INC
DATE OF NAME CHANGE: 20031230
4
1
wf-form4_161429071161279.xml
FORM 4
X0306
4
2021-02-23
0
0001274737
EXAGEN INC.
XGN
0001788393
Adawi Kamal
C/O EXAGEN INC.
1261 LIBERTY WAY
VISTA
CA
92081
0
1
0
0
Chief Financial Officer
Common Stock
2021-02-23
4
A
0
37500
0
A
37500
D
Stock Option(right to buy)
18.2
2021-02-23
4
A
0
12500
0
A
2031-02-22
Common Stock
12500.0
12500
D
Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2020, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control.
Represents 37,500 shares of restricted stock units.
The option is exercisable as it vests. 25% of the shares subject to the option vest on February 23, 2022, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control.
/s/ Kamal Adawi
2021-02-25